This Month in Psychopharmacology

Browsing articles in "Professional Improvement"

Highlights from 2023 NEI Congress: Scientific Poster Session Winners
November 10, 2023

The 2023 NEI Congress Scientific Poster Session was held on Friday, November 10th and featured 128 posters covering the full spectrum of mental health research and clinical data....

Suicide Risk Among Patients Hospitalized With Psychiatric Illness
October 26, 2023

Fifteen to thirty percent of patients with a history of concussion present with persistent postconcussion symptoms. Individuals with persistent postconcussion symptoms are at greater risk of developing depressive symptoms. In a recent meta-analysis of...

Continue reading (Members only)

Meet DEA Training Requirements
October 16, 2023

Activities available as part of NEI Membership can fulfill the new, one-time eight-hour Drug Enforcement Administration requirement of the Medication Access and Training Expansion Act for all registered practitioners on treating and managing patients with opioid or other substance use disorders . ....

Updates to DSM-5-TR Criteria and Text
September 13, 2023

The American Psychiatric Association (APA) released DSM-5-TR™ Update, a supplement to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). The supplement reflects approved updates to diagnostic criteria and related text, as well as...

Continue reading (Members only)

CDC Estimates Suicides in U.S. Reached All-Time High in 2022
September 1, 2023

Provisional data released by the Center for Disease Control and Prevention (CDC) indicate that in 2022 there were 49,449 deaths from suicide in the United States. These data are quite disheartening especially given that deaths by suicide had declined in 2019 and 2020, only to rise by 5% in 2021; the provisional 2022 data represent a further 2.6% increase. When demographic data are evaluated, it can be seen that suicide death rates increased in...

World Schizophrenia Day: Education and Tool for Providers
May 24, 2023

The high rates of treatment resistance, relapse rates, and incidence of adverse effects in patients with schizophrenia suggest that a major treatment gap continues to still exist. Education is an essential tool in order for clinicians to integrate the new data, treatment options, and recommended management strategies into clinical practice as they become available...

2023 NEI Synapse: Biggest Mistakes in Psychopharm
April 2, 2023

On Saturday, April 1, we rounded out a fantastic 2023 NEI Synapse meeting with a special “Biggest Mistakes in Psychopharm” session. During this session, Drs. Manpreet Singh, Thomas Schwartz, and Andrew Cutler shared some of the common mistakes mental health care clinicians make in diagnosis and treatment of various mental health conditions and concerns...

FDA Approves First Over-the-Counter Naloxone Nasal Spray
March 29, 2023

The U.S. Food and Drug Administration approved naloxone hydrochloride nasal spray for over-the-counter, nonprescription, use. This overdose-reversing drug is the first opioid treatment drug to be sold over-the-counter. The approval of over-the-counter naloxone nasal spray will require...

The Future of Psychopharmacology
February 9, 2023

It is an incredible time in terms of the development of new psychopharmacological agents with novel mechanisms of action. In this article, leading experts in the field of psychopharmacology discuss the most promising medications in Phase II and III clinical trials that are being investigated for schizophrenia, bipolar disorder, major depressive disorder, anxiety, substance use disorders, and dementia...

Continue reading (Members only)

Severe Mental Illness and Mass Murders in Academic Settings
December 6, 2022

Identifying consistent patterns among perpetrators of mass murders in academic settings, particularly by firearms, is critical for prevention efforts. Severe mental illness (SMI) is a hypothesized risk factor that has not been reliably predictive. A recent study compared mass shootings with mass murders by means other than firearms occurring in schools, colleges, and universities, while examining the relationship between...

Top of Page